fda_approval · anda · info
NOVITIUM PHARMA — ANDA approval: RIFAMPIN (unspecified)
- Event date
- 2026-06-29 00:00:00Z
- Observed
- 2026-07-09 22:53:29Z
- Source ID
- ANDA219918-1
- Payload hash
- d51a5235a91992079001d85c…
Summary
NOVITIUM PHARMA received ANDA approval for RIFAMPIN (unspecified) on 2026-06-29. Dosage form: CAPSULE. Application #: ANDA219918.
Entities
Informational only. Not legal, financial, or medical advice.